Regeneron and MTPC Announce Japanese Collaboration

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a collaboration with Mitsubishi Tanabe Pharma Corporation (TSE: 4508) (MTPC) providing MTPC with exclusive development and commercial rights to fasinumab (REGN475), Regeneron’s NGF antibody in late-stage...

Armetheon Announces Asian commercialization agreement

Armetheon and Lee’s Pharma Enter into Agreement to Develop and Commercialize Tecarfarin in Greater China and Thailand MILPITAS, Calif. and HONG KONG, Sept. 22, 2015 /PRNewswire/ — Armetheon, Inc., a specialty pharmaceutical company developing novel small...